Abstract:Background: The relationship of patient characteristics and social determinants of health (SDOH) with hospitalizations and costs in patients with major depressive disorder (MDD) has not been assessed using real-world data. Objective: To identify factors associated with higher hospitalizations and costs in patients with MDD. Methods: A retrospective observational study identified patients aged 18 years and older newly diagnosed with MDD between July 1, 2016, and December 31, 2018. SDOH were linked to patients at the "near-neighborhood" level. Multivariable models assessed association of patient characteristics with hospitalizations (incidence rate ratios [95% CI]) and costs (cost ratios [95% CI]). Results: Of 1,958,532 patients with MDD, 49.6% had Commercial and 50.4% Medicaid insurance; mean ages were similar (43.9; 43.4) with more female patients (67.6%; 70.5%). MDD patients with Commercial insurance had a mean household income of $75,044; 53.2% were married; 76.5% owned their home; 64.4% completed high school or less; and 2.8% had limited English-language proficiency (LEP). Patients covered by Medicaid had a household income of $46,708; 68.1% lived alone with 41.6% married; 54.6% owned their home; more than 4-in-5 patients (80.8%) completed high school or less, and 6.3% had LEP. Nearly one-third of Medicaid insured patients with MDD had at least 1 hospitalization (29.6%) with a mean length of stay 6.8 days; total health care costs were $21,467 annually. Commercially insured patients with MDD had 14.7% hospitalization rates with a length of stay of 5.9 days; total costs were $14,531. Multivariable models show female patients are less likely (Commercial 0.87; Medicaid 0.80; P < 0.05), and patients with more comorbidities are more likely to be hospitalized (Commercial 1.33; Medicaid 1.27; P < 0.05). All treatment classes relative to antidepressants only increased likelihood of hospitalizations-particularly antipsychotic+antianxiety use (Commercial 2.99; Medicaid 2.29)-and costs (Commercial 2.32; Medicaid 2.00) (all P < 0.05). Household income was inversely associated with hospitalizations for both insured populations. LEP reduced the likelihood of hospitalizations by more than 70% among Medicaid patients (0.27, P < 0.05) and was associated with higher costs for Commercial (2.01) but lower costs for Medicaid (0.37) (P < 0.05). Living in areas with no shortage of mental health practitioners was associated with higher hospitalizations and costs. Conclusions: We identified patient characteristics associated with higher rates of hospitalizations and costs in patients with MDD in 2 insured populations. Female sex, higher comorbidities, and living in areas with no shortage of mental health practitioners were associated with higher hospitalizations and costs, whereas income was inversely associated with hospitalizations. The findings suggest disparities in access to care related to income, LEP, and availability of mental health practitioners that should be addressed to assure equitable care for patients with MDD.

Differences across race and ethnicity in the quality of antidepressant medication management

Differences in schizophrenia treatments by race and ethnicity—analysis of electronic health records

Differences in Primary Care Management of Patients With Adult Attention Deficit Hyperactivity Disorder (ADHD) Based on Race and Ethnicity

Heterogeneity in Antidepressant Treatment and Major Depressive Disorder Outcomes Among Clinicians

Consumer Assessment of Healthcare Providers and Systems Among Racial and Ethnic Minority Patients With Alzheimer Disease and Related Dementias

Racial Differences in Satisfaction with VA Health Care: A Mixed Methods Pilot Study

Exploring Antidepressant Adherence at a Student-Run Free Mental Health Clinic

Attitudes towards depression and its treatment among white, hispanic, and multiracial adults

Racial Disparities In Outpatient Medical Management Of Patients With Heart Failure With Reduced Ejection Fraction

Differences in quality of anticoagulation care delivery according to ethnoracial group in the United States: A scoping review

Racial Differences in Visit Duration of Outpatient Psychiatric Visits

Examining racial/ethnic inequities in treatment participation among perinatal individuals with depression

Ethnic Determinants of Health and Medication Use for Depression Among US Latinx Adults

Racial/Ethnic Disparities in Primary Care Quality among Type 2 Diabetes Patients, Medical Expenditure Panel Survey, 2012

Racial and ethnic disparities in medication adherence among privately insured patients in the United States

Relationship between social determinants of health and hospitalizations and costs in patients with major depressive disorder

Abstract 146: Racial Disparities In The Treatment Of Post-stroke Complications Among Acute Stroke Patients

0270 Racial/Ethnic Sleep Health Related to Mental Health: Data from the National Sleep Foundation Sleep in America Poll

Treatment resistant depression: A comparative study of access, pathways, and outcomes between Caucasian and ethnic minority individuals

Quality of Depression Care for Veterans Affairs Primary Care Patients with Experiences of Homelessness

Effect of quality improvement on racial disparities in diabetes care.